StockGlow

Idorsia Ltd (IDRSF)

Develops medicines for brain disorders, heart disease, and rare genetic conditions.

$7.60+0.00%Healthcare
Compare IDRSF with
StockGlow Score
92
Bullish
BearishBullish
1 year ago+122.8%

The outlook

IDRSF is trading near the upper end of its 52-week range and sits above both its 50- and 200-day moving averages, reflecting a sustained uptrend. Analyst coverage appears thin, so sentiment data is limited. The stock's current positioning suggests strength in its recent momentum.

What’s behind the score

Price trendAbove its 50- & 200-day averages
52-week range88% of the way from its 52-week low to high
Market cap
$1.94B
52-wk high
$8.19
52-wk low
$3.30
50-day avg
$6.79
200-day avg
$5.16
Trailing P/E
—

Similar stocks

UCBJYUCB SA$142.43+1.98%GNMSFGenmab A/S$282.00+2.73%CMXHFCSL Limited$77.89-4.97%IVBXFInnovent Biologics, Inc.$10.86-15.16%WXIBFWuXi Biologics (Cayman) Inc.$4.60+0.00%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy